Interphase cytogenetics by means of in situ hybridization with the chromosome 12-specific biotinylated Q satellite DNA probe pSP 12-1 was used for the study of trisomy 12, the most common chromosomal abnormality in chronic lymphocytic leukemia. In situ hybridization was performed on methanol/acetic acid fixed cells of conventional cytogenetic preparations from eight patients and on morphologically and immunologically classified cells of cytospin preparations from seven patients. The results show that trisomy 12 is more common than assumed on the basis of karyotype analysis of metaphase chromosomes: 2 of 13 patients with a HRONIC LYMPHOCYTIC leukemia (CLL) is the C most prevalent form of human leukemia's* and, with the rise in the mean age of the population, its incidence is steadily increasing. In most cases of CLL the neoplastic cells represent B cells; in less than 5% of the cases the cells are of T-cell origin.'
the rise in the mean age of the population, its incidence is steadily increasing. In most cases of CLL the neoplastic cells represent B cells; in less than 5% of the cases the cells are of T-cell origin. ' Chromosome analyses with banding techniques after culturing the cells with so-called polyclonal B-cell mitogens such as Epstein-Barr virus, lipopolysaccarides, protein A, and pokeweed mitogen have shown clonal chromosome aberrations in approximately 50% of CLL cases; in the remaining cases, metaphase cells with normal chromosomes or only interphase cells are seen:,' This finding might be explained by the malignant clone being unable to divide in vitro or by the malignant clone being in fact karyotypically normal. Both of these hypotheses have received support in the literature.'.' By studying the chromosomes of morphologically and immunologically classified cells (MAC method), we have previously shown that in most of the cases where karyotype analysis showed a normal karyotype the metaphase cells studied were normal nonclonal T cells.' In some cases they were clonal K-positive or A-positive cells but still with a normal karyotype. Southern blotting DNA studies with probes that detect restriction fragment length polymorphism (RFLP) also support the notion that the karyotypic study of metaphase cells does not always yield information about the neoplastic cell pop~lation.'~~ Another sensitive method is provided by in situ hybridization with DNA probes detecting repetitive target DNA sequences of specific chromosomes, which enables one to study numerical chromosome aberrations in interphase nuclei (interphase cytogenetics)?- '2 Because trisomy 12 is the most common chromosome abnormality in CLL (more than 30% of cases with clonal chromosome aberrations) and is suggested to have prognostic v a l~e ,~, '~ we have performed an interphase gtogenetic study on 15 patients with CLL, using a chromosome 12-specific a satellite DNA probe. Our results show that trisomy 12 is more common than assumed on the basis of karyotype analyses of metaphase chromosomes and that trisomy 12 is restricted to cells with light chain clonality.
MATERIALS AND METHODS

Patients.
Fifteen patients with CLL were studied. The patients were selected on the basis of previous cytogenetic findings. Thirnormal karyotype in G-banding analysis were shown to have trisomy 12 by interphase cytogenetics. lmmunophenotyping of the cells of one patient showed that the trisomy was restricted to cells with lg light chain clonality. For the evaluation of the prognostic, therapeutic, and biologic significance of trisomy 12, in situ hybridization should be used in parallel with karyotype analysis because it allows the study of all cell populations of both interphase and mitotic cells, whether neoplastic or normal.
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teen of the patients (nos. 1 through 13) had been found to have a normal karyotype in studies conducted between January 1989 and February 1990 at the Department of Hematology and Oncology of the Hospital de la Cruz Roja de Barcelona, Spain. During this period, this laboratory performed chromosome analyses on a total of 23 patients with CLL; 16 of them proved to have a normal karyotype and seven an abnormal one. Of the seven patients with an abnormal karyotype, one had trisomy 12. One patient (no. 14) with trisomy 12 was selected as a positive control [47,XX,+12,t(7; 13)(q21;q14)]. In addition, one patient (no. 15) with a structural aberration of chromosome 12 was included in the study (46,XY,l2~+,13q-,17q-). This patient most probably had a three-way balanced translocation between chromosomes 12, 13, and 17, and thus no additional chromosome 12 material was present. Table 1 shows the hematologic and clinical characteristics as well as immunophenotypes of neoplastic cells of the patients studied. Specimens from six healthy persons (ages 28 to 44 years) known to have normal karyotype were used as negative controls.
Hematologic, cytogenetic, and immunologic analyses were performed on the same blood samples. In every patient, mononucleated cells from the peripheral blood were isolated by one-step density-gradient centrifugation in Ficoll-Paque (Pharmacia Fine Chemicals, Uppsala, Sweden) and washed twice with phosphate-buffered saline. Cytospin preparations were made and stained by immunoperoxidase or alkaline phosphatase antialkaline phosphatase technique as de- Whole blood was used for 3-day cell cultures. One culture was set up in the presence of pokeweed mitogen (PWM; 100 pg/mL; GIBCO, New York, NY) and one in the presence of 12-0-tetradecanoylphorbol-13-acetate (TPA, 2 pg/mL; Sigma, St Louis, MO). To arrest the metaphases, the cultures were treated with 0.125 pg of deacetylmethylcolchicine (Colcemid; GIBCO). For chromosome preparations, the cells were subjected to hypotonic treatment with a 0.56% solution of potassium chloride for 10 minutes. The cells were fixed in methanol/ acetic acid (3:l) for 40 minutes. After centrifugation, the cells were resuspended in fixative, dropped onto slides, and air-dried. The preparations were stained by a standard trypsin-Giemsa G-banding procedure (GTG). For patient nos. 4 through 9 and 12 through 15,20 metaphases from PWM-stimulated and 20 metaphases from TPA-stimulated cultures were analyzed, whereas for patient nos. 1 through 3 and 10 through 11,20 metaphases from TPA-stimulated cultures only were studied. MAC preparations were made of noncultured cells. Thus, only interphase cells were analyzed. The MAC (morphology-antibodychromosomes) technique has been described earlier.14-16 Briefly, mononucleated cells from the peripheral blood were isolated by one-step density-gradient centrifugation in Ficoll-Paque and washed twice with phosphate-buffered saline. For immunologic classification, 1 million cells were suspended in 1 mL of RPMI 1640 medium, to which 1 mL of hypotonic solution was added. The hypotonic solution consisted of 50 mmoliL of glycerol, 5 mmol/L of potassium chloride, 10 mmol/L of sodium chloride, 0.8 mmol/L of magnesium chloride, 1 mmol/L of calcium chloride, and 10 mmolL of sucrose. After hypotonic treatment for 5 minutes, the cell Conventional cytogenetic preparations.
MAC preparations of immunologically classifid cells.
suspension was divided into cytocentrifuge chambers and centrifuged at 4% for 10 minutes. After air-drying ovemight, the cells were identified by immunoperoxidase or alkaline phosphatase antialkaline phosphatase technique using the following antibodies: Leu14 (anti-CD22), anti-K, anti-A, and Leu4 (anti-CD3).
The hybridization was performed with a biotin-labeled, chromosome 12-specific c1 satellite DNA probe pSP12-1, containing a 340-bp EcoRI fragment." Previous experiments using fluorescence in situ hybridization have shown that this probe is highly specific for the centromeric region of chromosome 12 and displays essentially no cross-hybridization with other chromosomes at high stringency." The probe was labeled by nick-translation using biotin-11-dUTP (Bethesda Research Laboratories, Gaithersburg, MD) or biotin-16-dUTP (Boehringer Mannheim, GmbH, Germany) according to the instructions of the supplier. Hybridization was performed by a modification of methods described earlier.11. '8'20 Conventional cytogenetic preparations (patient nos. 1 to 8) were made from methanouacetic acid-fixed cell suspensions (stored at +4"C for 1 to 6 months) derived from TPA-stimulated cultures. Fresh slides were incubated in sequential ethanol series (70%, 94%, 99%; 5 minutes each) and air-dried for a few hours. MAC preparations of immunologically classified cells (patient nos. 9 through 15) were destained by incubation in methanol/acetic acid tixative for 1 hour at room temperature and air-dried for 1 to 4 hours. The preparations were then, right away or after storage at -70°C for 0.5 to 2 months, incubated in 0.01 N hydrochloric acid containing 0.01 to 0.1 mg of pepsin per milliliter at 37°C for 4 to 10 minutes to remove the cytoplasm. To stop the reaction, the slides were washed in distilled water for 2 to 3 minutes, which was followed by sequential incubation in ethanol. The slides were allowed to dry at room temperature for 1 to 4 hours before the hybridization was performed.
Immediately before hybridization the slides were incubated in a solution consisting of 60% formamide, 2X standard saline citrate
In situ hybridization.
For 
RESULTS
In situ hybridization was performed on specimens from 15 patients with CLL. In the case of patient nos. 1 through 8, in situ hybridization was performed on fresh conventional cytogenetic preparations. In these patients, previous chromosome studies had shown a normal karyotype. (Fig 1) .
In the case of seven patients, in situ hybridization was performed on MAC preparations. Previous G-banding analyses had shown a normal karyotype in five of these patients (nos. 9 through 13); patient no. 14 exhibited trisomy 12 in 50% of the metaphases analyzed, and patient no. 15 had a structural aberration of chromosome 12 in 15% of the metaphases analyzed. Of these seven patients, only patient no. 14 had cells with three in situ hybridization signals. In this patient, the frequencies of cells with three and two (or fewer) were 81% and 19%, respectively, when counted without regard to cell subset. In this patient in situ hybridization signals were also analyzed from CD3, K, and A positive cells. Eighty-seven percent of the A positive B cells had three signals, whereas in none of the cells positive for K and T-cell markers three signals were seen ( Table 3) .
In MAC preparations from the three controls the frequency of two signals was 90% to 93%. The corresponding figure in conventional preparations from the three other controls was 73% to 95%. These figures demonstrate that MAC preparations are equally suitable for in situ hybridization as are conventional cytogenetic preparations. In the six controls, none of the cells contained three hybridization signals. 
0
Karotypes of patient nos. 1 through 13 were normal. Karyotypes of patient nos. 14 and 15 were 47,XX,+lZ,t(7;13)(q21;q14) and 46,XY,12p+,l3q-,17q -, respectively. *Percentages counted without regard to cell subset. See Table 3 for analysis of immunologically classified cells.
DISCUSSION
The present study shows that the characterization of human chromosomes in interphase nuclei by in situ hybridization is a powerful method in the study of chromosomal aneuploidy. Especially in CLL, in which the neoplastic B cells often fail to proliferate actively despite polyclonal B-cell activators, the advantages of this technique become evident. Thus, in a study using in situ hybridization, one can easily analyze up to 250 cells, which would be very laborious in conventional karyotype analysis. In our study the possibility to use large numbers of cells provided new information about the frequency and lineage specificity of trisomy 12 in CLL.
Our results show that trisomy 12 is more common than expected on the basis of standard cytogenetic G-banding analyses. Results by Einhorn et who used Southern blotting analysis with probes that detect RFLPs on chromosome 12, corroborate our findings indicating that the proportion of normal metaphases does not match the proportion of cells lacking the trisomy. However, these investigators were unable to find any trisomy 12 patients not detected in conventional karyotype analysis. In our small patient material we were able to find two cases of trisomy 12 previously undetected by karyotype analysis. Therefore, standard chromosome banding analysis of metaphase cells does not appear to be a sensitive method of detecting aneuploidy in CLL. Discrepancies between various studies
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concerning the prognostic significance of trisomy 123r6,*'-B might be explained by this methodologic inadequacy. As in situ hybridization technique is rapid and relatively easy to use, more CLL cases should be studied using the chromosome 12-specific DNA probe before one can reliably estimate the prognostic importance of this trisomy. To fully elucidate the clinical and biologic significance of trisomy 12, interphase cytogenetics should be used simultaneously with metaphase cytogenetics.
In addition to trisomy 12, there are other chromosome abnormalities, some with prognostic value, eg, of chromosomes 13 and 14, often detected in CLL? Because only a 12-specific probe was used in our interphase cytogenetic study, we cannot rule out the possibility that the patients might also have had other chromosomal abnormalities. Thus, interphase cytogenetics cannot replace karyotype analysis of metaphase cells. The methods are mmplementary.
None of our healthy controls showed three signals for chromosome 12 in 200 to 250 cells scored from a predetermined area of the slide. The proportion of control cells with two signals was 73% to 95%, but never 100%. Whether cells of zero or one spot represent nullisomi or monosomy 12, or whether they are due to poor penetration of the probe, incomplete denaturation of target DNA or possible damage in DNA during long storage of the cells in fixative is not known. With chromosome 7 or 9 specific probes, the frequencies of cells with zero or one hybridization spot has been reported to be as high as ll%.24s25 Thus, it is evident that this technique should be used with great caution for analysis of monosomy of low frequency. Even though the frequency of the cells with only one signal was as high as 13% to 19% in patient nos. 1, 6, 8 , and 15 and in control no. 3 , we do not consider these patients necessarily as cases of monosomy 12. Similarly, it should be noted that cases with a very low frequency of trisomic cells may remain undetected for the reasons mentioned above, and finally, that in patient nos. 3 and 5, who had three signals in a small proportion of their cells, trisomy 12 cannot be interpreted to be present only in some of the neoplastic cells. In patient no. 3 any definite conclusions are also hindered by the fact that light chain clonality was not determined, and thus it is possible that some of the B cells are not clonal neoplastic cells. Further studies are needed to confirm the existence of "preneoplastic" cells without the trisomy.
The restriction of trisomy 12 to clonal B cells in patient no. 14 confirms our earlier findings made by MAC study of metaphase cells.26 Because only metaphase cells were analyzed in the previous study, we did not find out whether nonclonal B cells also had the abnormality. In the case of patient no. 14, who exhibited A clonality, K positive cells accounted for less than 1% of all cells. Nevertheless, it was not difficult to find 200 cells for analysis. None of these cells contained trisomy 12. The frequency of A positive cells with two signals was 8%. Whether these "disomic" cells represent normal, nonclonal positive B cells or disomic "preneoplastic cells" cannot be solved because the hybridization is never 100% effective.
In conclusion, the combination of MAC and in situ hybridization proved useful in the study of CLL, showing that standard karyotype analysis fails to show all patients with trisomy 12, and that trisomy 12 is restricted to cells with Ig light chain clonality. The combination is superior to karyotype analysis in the study of trisomy 12 in CLL because it allows the study of all cell populations of both interphase and metaphase cells, whether neoplastic, or normal. No mitogens are required. On the other hand, the method can be used to study the effect of polyclonal B-cell activators or B-cell growth factors on the different lympho- 27. Kovanen PE, Franssila K, Peltomaki P, Knuutila S: Effect of a low-molecular-weight B cell growth factor on the proliferation of normal and neoplastic lymphocytes in lymphomas. Cancer Genet Cytogenet 48:109,1990 J Pathol135: 1105, 1989 For personal use only. on October 30, 2017. by guest www.bloodjournal.org From
